Last updated: 2026-10-13 15:40:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
RadNet, Inc. (RDNT) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $71.78, with a market capitalisation of $5.58B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $50.82 to $85.84. This page covers its latest market performance, valuation, price trends and company information.
$5.58B | |
$70.81 | |
$93.65 | |
$0.85 | |
$71.49 | |
116.07K | |
707.24K | |
-- | |
$85.84 | |
$50.82 | |
-- | |
-- |
RadNet, Inc. (RDNT) is currently trading at $71.78 as of 2026-10-13 15:39:00, up 0.40% ($0.29) from the previous close of $71.49
During today's regular trading session, RDNT has traded between $0.85 and $93.65, with a trading volume of 116.07K shares. The current price is near the upper end of today's range.
Over the past seven days, RadNet, Inc. (RDNT) moved from $69.93 to $71.78, representing a gain of 2.64% ($1.85).
The stock traded between $66.23 and $72.96 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 508.43 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 59.8%
RDNT is currently trading at $71.78, placing it 59.8% of the way from its 52-week low of $50.82 to its 52-week high of $85.84. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 11264 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of RadNet, Inc. (RDNT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.